Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

Novartis heart drug sees stellar results

September 1, 2014
Sales and Marketing Diovan, LCZ696, Novartis, failure, heart, valsartan

Novartis’ new heart pill has produced stellar results in helping patients with heart failure live longer, making it the first …

News
donald_johns_biogen_idec

Biogen Idec hires from Novartis to head ALS

September 1, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, Novartis, als, donald johns

Biogen Idec has appointed Dr Donald Johns as the vice president of its amyotrophic lateral sclerosis (ALS) innovation hub unit. …

Appointment
Novartis HQ

Novartis must drop vaccine price, says UK govt

August 5, 2014
Medical Communications, Sales and Marketing Bexsero, Novartis, innoculation, meningococcal vaccine

Novartis will have to significantly lower the price of its meningococcal B vaccine if it wants a lucrative UK inoculation …

News

Novartis makes Alzheimer’s deal

July 16, 2014
Research and Development, Sales and Marketing Alzheimer's, Genentech, Novartis, bai, epstein

Novartis is to collaborate with the Banner Alzheimer’s Institute (BAI) to test two of the Swiss company’s investigational anti-amyloid treatments. …

News
Lens image

Novartis forms alliance with Google on ‘smart lens’

July 15, 2014
Medical Communications, Sales and Marketing Alcon, Novartis, diabetes, e-health, google, smart lens, wearable

Novartis eye care division Alcon has struck a deal with Google to develop a ‘smart’ contact lens designed to help …

News
novartis image

Novartis faces data fraud charges in Japan

July 3, 2014
Medical Communications, Sales and Marketing Diovan, Japan, Novartis, data, fraud, heart, valsartan

Novartis is facing criminal charges in Japan over the alleged falsifying of data for its once big-selling heart drug Diovan. …

News

France ‘to approve’ Avastin use

July 3, 2014
Sales and Marketing AMD, France, Lucentis, Novartis, Roche, avastin, off label, off-label, wet AMD

The French government is planning to allow Roche’s cancer drug Avastin to be prescribed off-label to treat wet age-related macular …

News
Glivec image

NICE U-turn on cancer drug despite price increase

June 27, 2014
Sales and Marketing Cancer, Glivec, NHS, Novartis, gists

UK pricing watchdog NICE has performed a U-turn on Glivec (imatinib) by issuing new draft guidance recommending the drug, despite …

News
Diovan image

Ranbaxy’s Diovan copycat approved in US

June 27, 2014
Manufacturing and Production, Sales and Marketing Diovan, FDA, Novartis, Ranbaxy, blood pressure, sun pharmaceuticals, valsartan

Ranbaxy has won approval for its copycat form of Novartis’ blockbuster blood pressure drug Diovan, as the Swiss firm finally …

News

Novartis back under microscope

June 23, 2014
Medical Communications, Sales and Marketing Italy, Novartis, avastin, fraud, influenza, vaccines

Novartis is under the microscope yet again in Italy, with police visiting the company’s sites at Siena and Origgio in …

News

Novartis emphasises pharma growth

June 19, 2014
Sales and Marketing Novartis, breezhaler, dermatology, heart failure, oncology, respiratory

Novartis is to grow its pharma business by focussing on five key areas and predicts that it will have 14 …

News
Bruno image

Novartis hires Merck president to lead oncology

June 3, 2014
Medical Communications, Research and Development, Sales and Marketing Bruno Strigini, MSD, Merck, Novartis, oncology

Novartis has hired Merck’s president of Europe and Canada Bruno Strigini to be its president of oncology.  The role was …

News

Italy eyes €1.2 billion pharma fine

May 30, 2014
Sales and Marketing Novartis, Roche, avastin, off label, wet and

Italy’s health ministry says it is looking for €1.2 billion in damages from Roche and Novartis over claims that the …

News
Novartis image

Novartis pays $200m for eye technology

May 22, 2014
Sales and Marketing Novartis, eye technology, fovista, ophthotech, wet and

Novartis has bought the rights to licence and commercialise a novel anti-PGDF therapy which it is currently trialling in Phase …

News
Novartis logo

Novartis agrees Gleevec patent deal

May 19, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Gleevec, India, Novartis, Sun Pharma, patent

Novartis has settled patent litigation with Sun Pharmaceutical Industries in the US, paving the way for the Indian company’s subsidiary …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025